| Literature DB >> 22023793 |
Insook Kim1, Dongjin Yang, Xinyu Tang, John L Carroll.
Abstract
BACKGROUND: The carotid bodies are the main arterial oxygen chemoreceptors in mammals. Afferent neural output from the carotid bodies to brainstem respiratory and cardiovascular nuclei provides tonic input and mediates important protective responses to acute and chronic hypoxia. It is widely accepted that the selection of reference genes for mRNA normalization in quantitative real-time PCR must be validated for a given tissue and set of conditions. This is particularly important for studies in carotid body during early postnatal maturation as the arterial oxygen tension undergoes major changes from fetal to postnatal life, which may affect reference gene expression. In order to determine the most stable and suitable reference genes for the study of rat carotid body during development, six commonly used reference genes, β-actin, RPII (RNA polymerase II), PPIA (peptidyl-proyl-isomerase A), TBP (TATA-box binding protein), GAPDH, and 18s rRNA, were evaluated in two age groups (P0-1 and P14-16) under three environmental oxygen conditions (normoxia, chronic hypoxia and chronic hyperoxia) using the three most commonly used software programs, geNorm, NormFinder and BestKeeper.Entities:
Year: 2011 PMID: 22023793 PMCID: PMC3224571 DOI: 10.1186/1756-0500-4-440
Source DB: PubMed Journal: BMC Res Notes ISSN: 1756-0500
Information on the primers used for real time PCR
| Gene | Accession # | Primers | Product Size (bp) | Efficiency Rate (E) | |
|---|---|---|---|---|---|
| PPIA | NM_017101 | F | GTCAACCCCACCGTGTTCTTC | 133 | 1.93 |
| R | ATCCTTTCTCCCCAGTGCTCAG | ||||
| TBP | NM_001004198 | F | ACCGTGAATCTTGGCTGTAAAC | 123 | 2.06 |
| R | CGCAGTTGTTCGTGGCTCTC | ||||
| RPII | AB017711 | F | GGCTCTCCAGATTGCGATGTG | 124 | 1.93 |
| R | CAGGTAACGGCGAATGATGATG | ||||
| β-actin | NM_031144 | F | CAGGGTGTGATGGTGGGTATGG | 115 | 2.03 |
| R | AGTTGGTGACAATGCCGTGTTC | ||||
| GAPDH | NM_017008 | F | CAAGTTCAACGGCACAGTCAAG | 123 | 1.91 |
| R | ACATACTCAGCACCAGCATCAC | ||||
| 18s | X01117 | F | CACGGGTGACGGGGAATCAG | 105 | 2.03 |
| R | CGGGTCGGGAGTGGGTAATTTG | ||||
| TASK-1 | NM_033376 | F | GCAGAAGCCGCAGGAGTTG | 126 | 2 |
| R | GCCCGCACAGTTGGAGATTTAG | ||||
| TASK-2 | AM229406 | F | ACGCCCTCTACCGCTACTTTG | 129 | 2.12 |
| R | GCCGCCTCCTCCTCTTCTTG | ||||
| TASK-3 | NM_053405 | F | CGGTGCCTTCCTCAATCTTGTG | 144 | 1.8 |
| R | TGGTGCCTCTTGCGACTCTG |
Nucleotide sequences for the primers, size of PCR products, and PCR amplification efficiency rate of each primer set. All the genes are from rat origin. The real-time PCR efficiency rate (E) in exponential phase was calculated according to the equation: E = 10[-1/slope] [32].
Figure 1The distribution of gene expression levels of tested reference genes in pooled C. Data obtained from immature (N1), mature (N14), chronic hyperoxia (Hyper14), and chronic hypoxia (Hypo14) treated rat CB. Top panel: PCR amplicons from all tested reference genes were detected on 1.5% agarose gel as single band and correct size of PCR product. Bottom panel: CT values for each reference gene are shown as medians (line in box), means (asterisks), 25 to 75 percentile (boxes), and 1 to 99 percentile ranges (whiskers).
Ranking of the 6 selected reference genes in rat whole carotid bodies by geNorm, NormFinder and BestKeeper
| geNorm | N1+N14 (n = 16) | N14+Hyper14 (n = 14) | N14+Hypo14 (n = 14) | N1+N14+Hyper14+ Hypo14 (n = 28) | ||||
|---|---|---|---|---|---|---|---|---|
| Best two genes | RPII TBP | 0.26 | PPIA TBP | 0.20 | PPIA TBP | 0.29 | PPIA TBP | 0.26 |
| 3 | PPIA | 0.27 | RPII | 0.35 | RPII | 0.36 | RPII | 0.38 |
| 4 | actin | 0.34 | GAPDH | 0.43 | GAPDH | 0.45 | GAPDH | 0.44 |
| 5 | GAPDH | 0.38 | actin | 0.50 | actin | 0.50 | actin | 0.49 |
| 6 | 18s | 0.40 | 18s | 0.57 | 18s | 0.52 | 18s | 0.53 |
| N1+N14 (n = 16) | N14+Hyper14 (n = 14) | N14+Hypo14 (n = 14) | N1+ N14+Hyper14+ Hypo14 (n = 28) | |||||
| Rank | Gene | Variability | Gene | Variability | Gene | Variability | Gene | Variability |
| Best two genes | TBP Actin | 0.009 | RPII GAPDH | 0.007 | RPII GAPDH | 0.008 | PPIA TBP | 0.011 |
| 1 | GAPDH | 0.01 | RPII | 0.013 | TBP | 0.007 | TBP | 0.015 |
| 2 | PPIA | 0.011 | GAPDH | 0.013 | PPIA | 0.015 | GAPDH | 0.017 |
| 3 | actin | 0.014 | TBP | 0.014 | GAPDH | 0.018 | 18s | 0.019 |
| 4 | TBP | 0.015 | actin | 0.019 | RPII | 0.018 | PPIA | 0.020 |
| 5 | RPII | 0.016 | PPIA | 0.021 | 18s | 0.020 | RPII | 0.021 |
| 6 | 18s | 0.018 | 18s | 0.021 | actin | 0.021 | actin | 0.023 |
| N1+N14 (n = 16) | N14+ yper14 (n = 14) | N14+Hypo14 (n = 14) | N1 + N14 + Hyper14+ Hypo14 (n = 28) | |||||
| Rank | Gene | Coeff. of corr.[r] | Gene | Coeff. of corr.[r] | Gene | Coeff. of corr.[r] | Gene | Coeff. of corr.[r] |
| 1 | PPIA | 0.89 | RPII | 0.97 | RPII | 0.86 | PPIA | 0.97 |
| 2 | actin | 0.84 | PPIA | 0.96 | PPIA | 0.85 | TBP | 0.95 |
| 3 | GAPDH | 0.83 | GAPDH | 0.96 | TBP | 0.85 | GAPDH | 0.95 |
| 4 | 18s | 0.73 | TBP | 0.95 | actin | 0.75 | RPII | 0.93 |
| 5 | RPII | 0.72 | actin | 0.93 | GAPDH | 0.69 | actin | 0.92 |
| 6 | TBP | 0.70 | 18s | 0.87 | 18s | 0.56 | 18s | 0.89 |
The reference genes are ranked in several groups of CB as follows: N1+N14 = immature and mature CB, reared in normoxia (n = 16). N14+Hyper14 = mature normoxia and hyperoxia treated CB (n = 14). N14+Hypo14 = mature normoxia and hypoxia treated CB (n = 14). N1+N14+Hyper14+Hypo14 = immature, normoxia (N1), mature, normoxia (N14), mature, hyperoxia (Hyper14), and mature, hypoxia treated (Hypo14) CB (n = 28). Genes are ranked on their stability value calculated by each respective program: geNorm, M-value; NormFinder, Variability; and BestKeeper, Coefficient of correlation [r]. (n) = number of independent determinations.
Figure 2geNorm analysis of the 6 candidate reference genes in all pooled data from N1, N14, Hyper14, and Hypo14 rat CB (n = 28). Average expression stability of candidate reference gene was determined by stepwise exclusion of least stable genes. Lower M values indicate greater stability.
Consensus ranking
| Gene ranking for group N1+N14 (n = 16) | ||||
|---|---|---|---|---|
| 1 | RPII | GAPDH | PPIA | PPIA |
| 2 | TBP | PPIA | Actin | GAPDH |
| 3 | PPIA | Actin | GAPDH | Actin |
| 4 | Actin | TBP | 18s | RPII |
| 5 | GAPDH | RPII | RPII | TBP |
| 6 | 18s | 18s | TBP | 18s |
| Gene ranking for group N14+Hyper14 (n = 14) | ||||
| Rank Position | geNorm | NormFinder | BestKeeper | Consensus |
| 1 | PPIA | RPII | RPII | RPII |
| 2 | TBP | GAPDH | PPIA | TBP |
| 3 | RPII | TBP | GAPDH | GAPDH |
| 4 | GAPDH | Actin | TBP | PPIA |
| 5 | Actin | PPIA | Actin | Actin |
| 6 | 18s | 18s | 18s | 18s |
| Gene ranking for group N14+Hypo14 (n = 14) | ||||
| Rank Position | geNorm | NormFinder | BestKeeper | Consensus |
| 1 | PPIA | TBP | RPII | TBP |
| 2 | TBP | PPIA | PPIA | PPIA |
| 3 | RPII | GAPDH | TBP | RPII |
| 4 | GAPDH | RPII | Actin | GAPDH |
| 5 | Actin | 18s | GAPDH | Actin |
| 6 | 18s | Actin | 18s | 18s |
| Gene ranking for group N1+N14+Hyper14+Hypo14 (n = 28) | ||||
| Rank Position | geNorm | NormFinder | BestKeeper | Consensus |
| 1 | PPIA | TBP | PPIA | TBP |
| 2 | TBP | GAPDH | TBP | PPIA |
| 3 | RPII | 18s | GAPDH | GAPDH |
| 4 | GAPDH | PPIA | RPII | RPII |
| 5 | Actin | RPII | Actin | 18s |
| 6 | 18s | Actin | 18s | Actin |
Weighted rank aggregation was performed to combine the ordered lists of genes produced by geNorm, NormFinder, and BestKeeper to a consensus rank of genes.
Gene ranking and consensus ranking using SYBR green super mixtures from two different vendors, Bio-Rad and Applied Biosystems
| Gene and consensus ranking for group N1+N14 (n = 16) using Bio-Rad SYBR | |||||||
|---|---|---|---|---|---|---|---|
| Bio-Rad SYBR | |||||||
| Rank Position | geNorm | M-value | NormFinder | Variability | BestKeeper | Coeff. of corr. [r] | Consensus |
| 1 | TBP | 0.26 | GAPDH | 0.01 | PPIA | 0.89 | PPIA |
| 2 | RPII | 0.26 | PPIA | 0.011 | Actin | 0.84 | GAPDH |
| 3 | PPIA | 0.27 | Actin | 0.014 | GAPDH | 0.83 | Actin |
| 4 | Actin | 0.34 | TBP | 0.015 | 18s | 0.73 | TBP |
| 5 | GAPDH | 0.38 | RPII | 0.016 | RPII | 0.72 | RPII |
| 6 | 18s | 0.40 | 18s | 0.018 | TBP | 0.70 | 18s |
| Gene and consensus ranking for group N1 + N14 (n = 16) using Applied Biosystems SYBR | |||||||
| Applied Biosystems SYBR | |||||||
| Rank Position | geNorm | M-value | NormFinder | Variability | BestKeeper | Coeff. of corr. [r] | Consensus |
| 1 | PPIA | 0.21 | PPIA | 0.008 | PPIA | 0.99 | PPIA |
| 2 | GAPDH | 0.21 | GAPDH | 0.013 | GAPDH | 0.99 | GAPDH |
| 3 | Actin | 0.25 | Actin | 0.013 | Actin | 0.99 | Actin |
| 4 | RPII | 0.32 | RPII | 0.014 | RPII | 0.98 | RPII |
| 5 | TBP | 0.34 | TBP | 0.016 | TBP | 0.98 | TBP |
| 6 | 18s | 0.39 | 18s | 0.024 | 18s | 0.97 | 18s |
The reference genes are ranked for N1+N14 group by geNorm, Normfinder and BestKeeper and the consensus ranking determined by rank aggregation. (n) = number of independent determinations.
Relative gene expression ratios of three interest TASK channel genes, TASK-1, TASK-2, and TASK-3, were compared by using one least stable reference gene (18s rRNA) and two best stable reference genes (PPIA and TBP)
| Reference Gene | TASK-1 | TASK-2 | TASK-3 |
|---|---|---|---|
| 18s rRNA | 1.172 | 0.682 | 1.285 |
| PPIA & TBP | 0.69 | 0.29 | 0.925 |
The ratios and statistical p values of three interest genes in groups N1+N14 were analyzed by REST2009 software. (n) = number of independent determinations.